French want reimbursement concerns addressed
This article was originally published in Clinica
Executive Summary
The potential for the new French reimbursement system to put pressure on medical device pricing is a major concern for the newly appointed president of SNITEM, the French medical devices industry association. Patryck Breitburd, president of B Braun Medical, voiced his fears at the industry association's general assembly at the end of last month and asked the government to accept that medical devices need to be evaluated in a different way to pharmaceuticals.